PAR-25-165-Full-Announcement.html

This document appears to be a Full Announcement for the federal grant opportunity titled "Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)" with Solicitation Number PAR-25-165.

The purpose of this funding opportunity is to support preclinical HIV/AIDS research using NHP models performed by Early Stage Investigators (ESIs) within 10 years of their terminal degree or residency training, with at least 2 years of postdoctoral experience. The goal is to help advance these ESIs in HIV/AIDS research using NHP models and position them to be competitive for new research funding like the R01. Proposed projects must use NHPs as preclinical models for HIV/AIDS research. This funding initiative encompasses priorities from the NIH Strategic Plan for HIV and HIV-Related Research, including reducing HIV incidence, developing next-generation therapies, HIV cure research, and addressing comorbidities. The funding mechanism is a grant, and eligible applicant types include independent school districts, state/local governments, nonprofits, small businesses, and higher education institutions. The grant is assigned to the NIH's Research Infrastructure Programs (CFDA 93.351) and Mental Health Research Grants (CFDA 93.242) federal grant programs.